Overview
CME Group reported Q2 2026 revenue of $1.706 billion, up 0.8% year over year. Clearing and transaction fees — the company's primary revenue line — contracted 2.5% to $1.353 billion from $1.388 billion, but market data revenue surged 20.2% to $238.1 million from $198.1 million, cushioning the decline. On a first-half basis, revenue rose 7.6% and net income grew 10.8% to $2.196 billion from $1.981 billion. The company said at its July 22 earnings release that adjusted revenue, operating income, net income, and EPS for the first half were all all-time records (company press release). Meanwhile, $3.166 billion in dividends paid and $1.237 billion in share repurchases in the first half drove cash and cash equivalents down 51.5%, to $2.144 billion from $4.417 billion.
Note 1: CME Group is a U.S.-listed company. Its financial statements are reported in USD. All figures in the tables below are as originally reported, in millions of dollars. Note 2: All figures in this analysis are on a GAAP basis unless otherwise stated. The company's press release highlighted Q2 adjusted diluted EPS of $2.99, which differs from the GAAP figure of $2.88 by approximately $0.11. All EPS and operating margin discussions below are on a GAAP basis.
1. Consolidated Balance Sheet Analysis
1-1. Key Asset Comparison (Dec. 31, 2025 → Jun. 30, 2026)
| Item | Prior Period ($M) | Current Period ($M) | Change | Commentary |
|---|---|---|---|---|
| Cash and cash equivalents | 4,416.9 | 2,144.2 | -51.5% | Funded annual variable dividend and share repurchases |
| Accounts receivable, net | 639.2 | 753.1 | +17.8% | Revenue growth and billing timing |
| Property and equipment, net | 362.7 | 351.2 | -3.2% | Depreciation exceeds new CapEx |
| Intangible assets – trading products | 17,175.3 | 17,175.3 | 0.0% | Not amortized (CFTC product approvals have no expiration) |
| Intangible assets – other, net | 2,610.7 | 2,494.6 | -4.4% | Amortization of customer relationship intangibles |
| Goodwill | 10,514.7 | 10,505.8 | -0.1% | Minor foreign currency translation impact |
| Total assets | 198,424.2 | 194,676.6 | -1.9% | — |
Key observation: 81% of total assets of $194.7 billion — or $158.1 billion — consists of performance bonds and guaranty fund contributions posted by clearing members. Of that, $138.5 billion is deposited at the Federal Reserve Bank of Chicago (10-Q, Note 4). The entire reinvested cash pool, including Fed deposits, generated $2.760 billion in income in the first half (the Fed account's standalone contribution is not separately disclosed). CME effectively operates as a dual business: exchange operator and large-scale central bank cash parking facility.
The sharp decline in cash is not a distress signal. First-half dividends paid of $3.166 billion plus share repurchases of $1.237 billion total $4.403 billion in shareholder returns (per the cash flow statement). On a declared basis, dividends of $3.172 billion plus repurchases of $1.237 billion equal $4.409 billion.
1-2. Liability Structure
Financial liabilities: Long-term debt of $3.424 billion (versus $3.422 billion at year-end, essentially unchanged). Maturities are laddered — $500 million in 2028, $750 million in 2030, $750 million in 2032, $750 million in 2043, and $700 million in 2048 (aggregate face value $3,450 million; the $26 million difference from the $3.424 billion carrying value reflects unamortized debt discount and issuance costs) — with coupon rates ranging from 2.65% (2032 notes) to 5.30% (2043 notes). The structure allows for sequential refinancing starting with the 2028 maturity (3.75%) as rates decline. CME also maintains a $2.3 billion multicurrency revolving credit facility (maturing April 2030) and a $7.0 billion 364-day secured facility, both currently undrawn.
Operating liabilities: Accounts payable of $68.0 million (-5.3%), other current liabilities of $538.6 million (-5.3%), and contract liabilities of $52.8 million (versus $16.7 million at year-end, +216% — reflecting increased prepaid annual license fees). Performance bond-related liabilities of $158.1 billion are matched exactly to the corresponding asset-side deposits (pass-through structure).
1-3. Capital Structure
Total equity declined to $26.520 billion from $28.728 billion (-7.7%). Retained earnings fell 15.2% to $5.458 billion from $6.433 billion, as first-half dividends declared of $3.172 billion exceeded net income of $2.196 billion. The equity reduction is therefore an intentional contraction driven by aggressive shareholder returns, not an operating loss. Series G preferred shares (4,584,000 shares) converted on a one-for-one basis into Class A common shares (the 10-Q records this as 4,584, where share counts are in thousands) on March 5 — no additional dilution from a conversion premium.
2. Consolidated Income Statement Analysis
2-1. Key Revenue and Earnings Metrics (Q2)
| Item | Q2 2025 ($M) | Q2 2026 ($M) | Change |
|---|---|---|---|
| Revenue | 1,692.0 | 1,706.2 | +0.8% |
| Operating income | 1,129.3 | 1,107.1 | -2.0% |
| Operating margin | 66.7% | 64.9% | -1.8pp |
| Non-operating income | 201.0 | 220.6 | +9.8% |
| Pre-tax income | 1,330.3 | 1,327.7 | -0.2% |
| Effective tax rate | 22.9% | 21.5% | -1.4pp |
| Net income | 1,025.1 | 1,041.8 | +1.6% |
| Net margin | 60.6% | 61.1% | +0.5pp |
| Diluted EPS ($, GAAP) | 2.81 | 2.88 | +2.5% |
Analysis 1 — Revenue: Clearing and transaction fee revenue fell 2.5%, the primary drag on Q2's 0.8% overall growth. By asset class, interest rates (-6.2%, $461.6M→$433.0M), energy (-14.0%, $217.4M→$187.0M), metals (-9.9%, $85.1M→$76.7M), and FX (-5.0%) were all weak, while equity index derivatives held up at +7.4% ($301.6M→$324.0M). Without market data's +20.2% gain, total revenue would have fallen — removing the $40.0 million increase from market data's $238.1 million would leave $1,666.2 million in total revenue, below the prior-year $1,692.0 million. Market data revenue of $238.1 million was a quarterly record, per the company.
Analysis 2 — The clearing fee decline reflects price compression, not a volume collapse: This is a widely misread data point. The 10-Q MD&A identifies the cause: futures and options contract volume fell just 1% to 1.850 billion from 1.873 billion contracts, while average rate per contract (RPC) declined 2% to $0.678 from $0.690. RPC compression stems from (1) increased weighting of micro contracts in equity indexes, energy, and metals — which carry lower per-contract fees — and (2) a higher share of member trading. A partial offset came from rate increases implemented April 1. The company stated that Q2 average daily volume (ADV) of 29.84 million contracts was the second-highest Q2 on record, and open interest rose 8% year over year. Mapping energy and metals fee declines directly to a commodity cycle downturn is not well-supported by the data. The 10-Q in fact notes that energy and metals' volume share rose 1 percentage point in the first half.
Analysis 3 — Net income grew +1.6% because of the tax rate, not earnings power: Operating income fell 2.0% and pre-tax income edged down 0.2% to $1.328 billion from $1.330 billion, even after non-operating income grew to $220.6 million from $201.0 million. The entire Q2 net income gain traces to the effective tax rate falling 140 basis points to 21.5% from 22.9%. The quality of EPS growth of +2.5% must be evaluated with this in mind — tax rate relief is not a recurring line item.
On a first-half basis, clearing and transaction fees also grew 6.2% to $2.895 billion from $2.725 billion, as first-quarter strength more than offset the second-quarter decline.
2-2. Fixed vs. Variable Cost Analysis
Fixed-cost items (largely volume-independent): - Compensation and benefits: $233.5 million (+5.4%) — base salaries and employer taxes were slightly lower (-$0.3 million); increases in non-qualified deferred compensation (+$4.7 million) and stock-based compensation (+$4.1 million) contributed to the rise - Technology: $83.3 million (+17.5%) — the largest percentage increase, reflecting cloud and infrastructure investment - Depreciation and amortization: $28.2 million (+3.3%) - Amortization of purchased intangibles: $56.0 million (-0.2%)
Variable-cost items (volume-linked): - Licensing and fee agreements: $109.1 million (+13.4%) — index royalties (S&P, etc.) - Professional services: $29.1 million (-22.2%) — consulting cost reduction
Analysis: Total expenses rose 6.5% to $599.1 million from $562.7 million, outpacing revenue growth of 0.8% and producing negative operating leverage. The 17.5% surge in technology costs reflects CME's transition from a legacy exchange toward a data and cloud platform — a strategic choice with near-term margin costs. Operating margin contracted 180 basis points to 64.9% from 66.7%. That said, on a first-half basis, operating margin actually improved to 67.4% from 67.1% (total expenses rose 7% to $1.170 billion from $1.097 billion). Negative operating leverage is a single-quarter phenomenon at this point, not a confirmed trend.
3. Cash Flow Statement Analysis (H1, Six Months)
| Item | H1 2025 ($M) | H1 2026 ($M) | Change |
|---|---|---|---|
| Operating cash flow | 2,175.1 | 2,207.0 | +31.9 |
| Investing cash flow | (34.0) | (52.4) | -18.4 |
| Financing cash flow | 40,210.6 | (5,974.8) | -46,185.4 |
| Ending cash (including restricted) | 144,145.8 | 160,259.3 | +16,113.5 |
Detail: - Operating CF: Net income ($2.196 billion) and depreciation and amortization ($168 million) were the primary drivers. Cash taxes paid were $689.7 million, up 19% from $579.6 million in the prior year. - Investing CF: CapEx totaled $45.4 million (versus $32.6 million, +39%), reflecting expanded data center and technology infrastructure investment. - Financing CF swing: The prior-year period saw $43.263 billion in performance bond inflows versus a $1.545 billion outflow this period. This is outside CME's control — stripping out performance bond movements, the core financing activity was dividends paid of $3.166 billion plus share repurchases of $1.237 billion, totaling $4.403 billion in net outflows. The 10-Q explicitly attributes the year-over-year increase in financing outflows to "higher share repurchases" — repurchases grew from $8.2 million in the prior-year first half to $1.237 billion, while dividends paid rose 4.7% to $3.166 billion from $3.023 billion.
Free cash flow (FCF): $2.207 billion - $45.4 million = $2.162 billion. Dividends paid ($3.166 billion) exceed FCF, but CME's structure — regular quarterly dividends plus an annual variable dividend — is designed to draw down accumulated cash. The remaining share repurchase authorization is $1.5 billion (of the $3.0 billion program approved in December 2024, $1.5 billion has been utilized, per 10-Q notes).
4. Additional Analysis
1. Performance bond reinvestment — the rate cut impact is already in the numbers
Of the $2.760 billion in first-half reinvestment income, $2.515 billion (91.1%) was redistributed to clearing members (recorded as a non-operating expense), with CME retaining a net margin of $244.9 million (8.9%). Critically, Q2 gross reinvestment income was already in decline — falling 6.6% to $1.389 billion from $1.488 billion. The 10-Q attributes this directly to higher average reinvestment balances being more than offset by lower average yields. Rate cuts are not a future risk; they are already feeding through to the income statement.
The offset structure provides a buffer. CME's net margin on the same income line grew 8.8% to $123.1 million from $113.1 million in Q2, and rose 34.6% to $244.9 million from $181.9 million in the first half. Even as gross income declines, net retention can hold.
A rough sensitivity (this publication's estimate — not company guidance): a 25-basis-point IORB cut would reduce gross interest income from the $138.5 billion Fed deposit by approximately $350 million annually. Assuming the current ~91% redistribution rate holds, the direct impact on CME's pre-tax income would be roughly $31 million per year (~$24 million after applying the 21.5% effective tax rate), under 1% of annual net income. However, the redistribution rate contains both contractual and discretionary elements and is not a fixed constant; if redistribution shrinks, clearing members' incentive to post collateral at CME may weaken — a second-order effect that is the more important variable to watch.